Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $245.81 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $124.99 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $107.82 | 1 | $0 (2021) |
| JAZZ PHARMACEUTICALS INC. | $13.00 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $137.99 | 2 | Novo Nordisk Inc ($124.99) |
| 2021 | $107.82 | 1 | GlaxoSmithKline, LLC. ($107.82) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/30/2022 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: NEUROLOGY | ||||||
| 06/16/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Diabetes | ||||||
| 06/30/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $107.82 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 381 | 400 | $172,565 | $48,284 |
| 2022 | 2 | 177 | 180 | $76,611 | $25,852 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 352 | 371 | $163,611 | $45,508 | 27.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 15 | 15 | $4,740 | $1,562 | 33.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $4,214 | $1,214 | 28.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 107 | 110 | $48,471 | $16,440 | 33.9% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 70 | 70 | $28,140 | $9,411 | 33.4% |
About Dr. Emily Orr, MD
Dr. Emily Orr, MD is a Hospitalist healthcare provider based in Sugarland, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2019. The National Provider Identifier (NPI) number assigned to this provider is 1881154177.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Emily Orr, MD has received a total of $245.81 in payments from pharmaceutical and medical device companies, with $137.99 received in 2022. These payments were reported across 3 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($245.81).
As a Medicare-enrolled provider, Orr has provided services to 558 Medicare beneficiaries, totaling 580 services with total Medicare billing of $74,136. Data is available for 2 years (2022–2023), covering 5 distinct procedure/service records.
Practice Information
- Specialty Hospitalist
- Other Specialties Internal Medicine
- Location Sugarland, TX
- Active Since 03/22/2019
- Last Updated 12/15/2025
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1881154177
Products in Payments
- Ozempic (Drug) $124.99
- TRELEGY ELLIPTA (Drug) $107.82
- XYWAV (Drug) $13.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.